ALKS vs JPM · P/E 14, rev $1.56B vs P/E 14, rev $182.45B
Alkermes Plc (ALKS) versus JPMorgan Chase & Co (JPM) — a side-by-side from cached financials, not a winner call.
Alkermes Plc (ALKS) is a drug manufacturers - specialty & generic company listed on US.
JPMorgan Chase & Co (JPM) is a banks - diversified company listed on US. It is led by Jamie Dimon.
Latest reported ALKS revenue for 2024-12-31 was $1.56B. Net income was $367.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ALKS currently screens at market cap $4.78B and trailing P/E 13.8.
Latest reported JPM revenue for 2025-12-31 was $182.45B. Net income was $57.05B. Revenue was up 2.8% from 2024-12-31 to 2025-12-31. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
ALKS currently screens at market cap $4.78B and trailing P/E 13.8. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
Not investment advice. Open the ALKS and JPM stock pages for the full models.
Not investment advice.